{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-053715","form_type":"8-K","ticker":"KMTS","cik":"0001877184","company_name":"KESTRA MEDICAL TECHNOLOGIES, LTD.","filed_at":"2025-04-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.336061+00:00","generated_at":"2026-05-23T15:41:18.886124+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Kestra Q3 revenue $15.1M (+82% YoY); FY2025 guided $58-58.5M","bullets":["Revenue $15.1M in Q3 FY2025, up 82% YoY; gross margin improved to 43.4% from 10.6%.","GAAP net loss $21.8M vs $21.6M prior year; adjusted EBITDA loss $16.3M vs $16.2M.","Completed IPO in March 2025, raising net proceeds of $205.2M.","In-network covered lives for ASSURE system now exceed 285M; appointed Al Ford as CCO.","FY2025 revenue outlook $58M to $58.5M, representing 109%-110% growth vs FY2024."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-053715","json":"https://secwatch.observer/filing/0000950170-25-053715.json","markdown":"https://secwatch.observer/filing/0000950170-25-053715.md","text":"https://secwatch.observer/filing/0000950170-25-053715.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1877184/000095017025053715/0000950170-25-053715-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1877184/000095017025053715/ck0001877184-20250414.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T15:41:18.886124+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}